These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Update on renal osteodystrophy: pathogenesis and clinical management. Sakhaee K; Gonzalez GB Am J Med Sci; 1999 Apr; 317(4):251-60. PubMed ID: 10210362 [No Abstract] [Full Text] [Related]
3. The role of phosphate and other factors on the pathogenesis of renal osteodystrophy. Slatopolsky E; Rutherford WE; Martin K; Hruska K Adv Exp Med Biol; 1977; 81():467-75. PubMed ID: 899937 [No Abstract] [Full Text] [Related]
4. Aluminum: toxin or innocent bystander in renal osteodystrophy. Malluche HH; Faugere MC Am J Kidney Dis; 1985 Nov; 6(5):336-41. PubMed ID: 3904426 [No Abstract] [Full Text] [Related]
5. Prevention and treatment of renal osteodystrophy in children with chronic renal insufficiency and end-stage renal disease. Sanchez CP Semin Nephrol; 2001 Sep; 21(5):441-50. PubMed ID: 11559885 [TBL] [Abstract][Full Text] [Related]
6. Unresponsiveness of bone to PTH in aluminum-related renal osteodystrophy. Kawaguchi Y; Oda Y; Imamura N; Shigematu T; Kimura Y; Aizawa S; Fujimaki H; Shoji R; Tsukui I; Ogura Y Kidney Int Suppl; 1986 Feb; 18():S49-52. PubMed ID: 3457996 [No Abstract] [Full Text] [Related]
7. Recent advances in the management of renal osteodystrophy in children. Salusky IB; Ramirez JA; Goodman WG Curr Opin Nephrol Hypertens; 1993 Jul; 2(4):580-7. PubMed ID: 7859020 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. Ott SM; Maloney NA; Coburn JW; Alfrey AC; Sherrard DJ N Engl J Med; 1982 Sep; 307(12):709-13. PubMed ID: 6896740 [TBL] [Abstract][Full Text] [Related]
16. [Renal osteodystrophy: aluminium and secondary hyperparathyroidism]. de Vernejoul MC Rev Prat; 1990 Mar; 40(7):613-8. PubMed ID: 2326587 [TBL] [Abstract][Full Text] [Related]